Table 3.
MNA-SF at Follow-Up | NRS-2002 at Follow-Up | EVS At Follow-Up | ||||
---|---|---|---|---|---|---|
MNA-SF at Baseline | p-Value | p-Value | p-Value | |||
n | 92 | 88 | 92 | |||
Kappa (95% CI) | 0.42 (0.22–0.61) | 0.861 | 0.33 (0.19–0.47) | 0.339 | 0.17 (−0.02–0.36) | <0.001 |
PPV | 83% | 44% | 90% | |||
NPV | 58% | 97% | 25% | |||
Sensitivity | 78% | 96% | 69% | |||
Specificity | 66% | 48% | 57% | |||
Agreement | 74% | 63% | 67% | |||
NRS-2002 at baseline | ||||||
n | 88 | 84 | 88 | |||
Kappa (95% CI) | 0.42 (0.23–0.60) | 0.875 | 0.47 (0.30–0.63) | 0.432 | 0.15 (−0.01–0.30) | <0.001 |
PPV | 87% | 53% | 92% | |||
NPV | 54% | 95% | 23% | |||
Sensitivity | 68% | 92% | 59% | |||
Specificity | 79% | 64% | 69% | |||
Agreement | 72% | 73% | 54% | |||
EVS at baseline | ||||||
n | 91 | 87 | 91 | |||
Kappa (95% CI) | 0.03 (−0.08–0.13) | <0.001 | 0.02 (−0.01–0.05) | <0.001 | 0.22 (−0.04–0.48) | 0.200 |
PPV | 70% | 31% | 87% | |||
NPV | 50% | 100% | 100% | |||
Sensitivity | 98% | 100% | 100% | |||
Specificity | 4% | 3% | 14% | |||
Agreement | 69% | 32% | 87% |
Abbreviations; PPV: positive predictive value; NPV: negative predictive value; CI: confidence interval; MNA-SF: Mini Nutritional Assessment; NRS-2002: Nutritional Risk Screening-2002; EVS: Eating Validation Scheme. Bold indicates the screening tool applied at baseline or follow-up.